80wk Downtrend — falling+below (sma 3.31 vs px 1.39)
200wk Downtrend — falling+below (sma 160 vs px 1.39)
Short Attack — velZ +8.35 · age 23w×1.00 · 11.83%
About Biovie Inc
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: May 5, 2014
Headquarters: 680 W. Nye Lane, Carson City, NV, United States, 89703
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$1.65
Near-term / short-term trend
Weekly
40-Week SMA
$1.52
Medium-term trend
Weekly
80-Week SMA
$3.31
Cyclical trend (business cycle)
Weekly
200-Week SMA
$160.15
Secular trend (multi-year)
Monthly
10-Month SMA
$1.56
Near-term monthly trend
Monthly
20-Month SMA
$3.36
Medium-term monthly trend
Monthly
40-Month SMA
$63.32
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$6.00
resistance
3.87x
13 months ago
$39.70
resistance
1.27x
25 months ago
Historical Earnings Reactions (24 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-0.23%
-0.27%
41.67%
9.96%
-9.44%
1 Day
-0.82%
-0.77%
41.67%
9.96%
-29.34%
1 Week
3.34%
0.31%
50.00%
31.95%
-9.89%
2 Weeks
3.96%
-3.55%
45.83%
55.98%
-26.67%
1 Month
8.79%
-0.87%
47.83%
128.33%
-63.85%
Next earnings: November 9, 2026 (29 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Biovie Inc
(BIVI) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.